ArticleRegenerative biomaterials2026
A microgel-stabilized, light-controlled artificial energy supply module for efficient biosynthesis.
Article in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial energy supply modules that can produce adenosine triphosphate (ATP) through natural or synthetic structures are crucial for supporting artificial cells with therapeutic purposes. However, their advanced biomedical application is hindered by poor stability, short lifespan and low output efficiency. In this study, an artificial light-controlled energetic module with long-term activity, termed thylakoid-loaded microgel (TM), is created by encapsulating spinach-derived thylakoid into alginate/gelatin microgels. The TM effectively retains the photosynthetic light reactions of thylakoids, including the electron transfer capacity of photosystem II and ATP production, and releases the produced ATP to external environment. As a proof of concept, the TM successfully drives the luciferin/luciferase reaction both within and outside the microgel compartment. In addition, the encapsulated thylakoids exhibit a significantly prolonged activity, with the high photosystem II activity and ATP production lasting for at least 96 h. The long-term activity is attributed to the oxidation shielding efficacy, protein and pigment degradation inhibition and membrane structural stabilization. This study presents a strategy for developing artificial energy supply modules with efficient energy output and long-term activity, holding great promise in artificial cell construction and biosynthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.